
First trimester
Nuchal translucency
- When it is performed11 weeks and 1 day to 13 weeks and 6 days
- CRL45mm – 84mm
This ultrasound scan is performed from 11 weeks and 1 day to 13 weeks and 6 days (CRL 45 mm–84 mm). It is usually performed transabdominally, but in some cases it may be necessary to carry out the examination transvaginally.
The test in detailObjectives of the ultrasound examination
- Accurate dating of the pregnancy
- This is particularly important for women who cannot remember the date of their last menstrual period, have irregular menstruation, or conceived while breastfeeding or immediately after stopping the contraceptive pill. We measure the size of the fetus and, based on this, calculate the estimated due date (40 weeks).
- Assessment of the risk of Down syndrome and other chromosomal abnormalities
- Every woman should receive an assessment of her individual risk for this pregnancy. This is calculated by taking into account the mother’s age, the measurement of two hormones in her blood (PAPP-A and free beta-human chorionic gonadotropin), and four ultrasound markers: nuchal translucency (the fluid behind the fetus’s neck), which is the most important marker; the nasal bone; blood flow on the right side of the fetal heart (at the tricuspid valve); and blood flow in the fetal ductus venosus (a small vessel in its liver). Parents will receive comprehensive counseling regarding the significance of this risk and the various options for further testing.
- Diagnosis of multiple pregnancy
- Approximately 2% of natural conceptions and 10% of IVF conceptions result in a multiple pregnancy. Ultrasound can determine whether both fetuses are developing normally and whether the babies share the same placenta, which may lead to problems during pregnancy. In such cases, it would be advisable for the pregnancy to be monitored more closely.
- Diagnosis of certain major congenital anomalies
- Significant abnormalities may be visible at this gestational age, but the 20-week ultrasound scan is also necessary.
- Diagnosis of early pregnancy failure (missed miscarriage)
- Unfortunately, in 2% of women who attend for the nuchal translucency ultrasound scan, it is found that the fetus has died, often several weeks earlier and without any warning. Couples will receive comprehensive counselling regarding the possible causes of this problem and the options for the next steps that may be necessary.
- Risk assessment for pre-eclampsia and fetal growth restriction
- In all patients, at the end of the examination, blood flow in the mother’s uterine arteries will be measured ultrasonographically using Doppler assessment. The result of this examination can indicate which women are at increased risk of developing pre-eclampsia, mainly before 34 weeks, as well as which fetuses are at risk of developing growth restriction, primarily in the third trimester.
- Risk assessment for preterm birth
- In all patients, at the end of the examination, if they so wish, the length of the cervix will be measured transvaginally. We know that during pregnancy the cervix should be long and closed. In women who are found to have a short cervix during the examination, the risk of preterm birth is increased. Management in this case depends on the nature of the problem.
Individualized risk for Down syndrome
The vast majority of babies are normal. However, all women, regardless of their age, have a small risk of giving birth to a child with a physical and/or intellectual disability. In some cases, the abnormality is due to a chromosomal abnormality, such as Down syndrome.
The only way to know with certainty whether the fetus has a chromosomal abnormality is through a diagnostic invasive test, such as chorionic villus sampling (CVS) or amniocentesis. However, these tests carry a risk of miscarriage of approximately 1%.
It is up to you and your partner to decide whether the risk of the fetus having chromosomal abnormalities is high enough to justify invasive testing. As a guideline, an invasive test is usually offered if the risk of Down syndrome is 1 in 300 or higher.
The most accurate method for assessing the risk that the fetus has Down syndrome is performed between the 11th and 14th weeks of pregnancy and depends on the following:
- Maternal age
- Amount of fluid behind the fetal neck (nuchal translucency)
- Presence or absence of the fetal nasal bone
- Fetal heart rate
- The blood flow through the tricuspid valve of the fetal heart
- The blood flow through the ductus venosus in the fetal liver
- Presence or absence of any structural abnormalities
- Levels of the two hormones (free β-hCG and PAPP-A) in the mother’s blood
After the ultrasound examination, based on all the above factors, the estimated risk for Down syndrome will be discussed with you. Only you can decide whether you wish to undergo an invasive diagnostic test. Regardless of whether or not you have decided to have an invasive test, a detailed ultrasound examination at 20 weeks is recommended to check for structural abnormalities in the fetus.







